| Levomenthol | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
| Levomenthol | hsa00514 | Other types of O-glycan biosynthesis | 3.20E-02 | 2 | O15294, Q9NY28 | OGT, GALNT8 | More | |
| Levomenthol | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
| Levomenthol | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 1.34E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | |
| Levomenthol | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.20E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
| Levomenthol | hsa00982 | Drug metabolism - cytochrome P450 | 3.20E-02 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
| Levomenthol | hsa01524 | Platinum drug resistance | 1.13E-03 | 6 | P10415, Q13489, P98170, P78417, P23025, P43246 | BCL2, BIRC3, BIRC4, GSTO1, XPA, MSH2 | More | |
| Levomenthol | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
| Levomenthol | hsa03008 | Ribosome biogenesis in eukaryotes | 2.60E-03 | 5 | Q9NYH9, P78345, Q9BVP2, O15381, Q9GZY0 | UTP6, RPP38, GNL3, NVL, NXF2; NXF2B | More | |
| Levomenthol | hsa03013 | RNA transport | 1.24E-03 | 9 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3 | More | |
| Levomenthol | hsa03040 | Spliceosome | 5.79E-03 | 7 | Q14562, O43143, O60508, Q99633, Q13595, Q01130, Q9UMS4 | DHX8, DHX15, CDC40, PRPF18, TRA2A, SFRS2, PRPF19 | More | |
| Levomenthol | hsa04014 | Ras signaling pathway | 4.38E-02 | 5 | P20827, P49767, Q14644, P0DP23, P62873 | EFNA1, VEGFC, RASA3, CALM1, GNB1 | More | |
| Levomenthol | hsa04015 | Rap1 signaling pathway | 1.58E-02 | 6 | P20827, P49767, P63261, P25116, P0DP23, P17252 | EFNA1, VEGFC, ACTG1, F2R, CALM1, PRKCA | More | |
| Levomenthol | hsa04020 | Calcium signaling pathway | 1.16E-03 | 7 | Q16566, P17252, O15399, P25116, P0DP23, P23634, P49767 | CAMK4, PRKCA, GRIN2D, F2R, CALM1, ATP2B4, VEGFC | More | |
| Levomenthol | hsa04024 | cAMP signaling pathway | 2.84E-02 | 5 | P0DP23, P23634, Q16566, O15399, P25116 | CALM1, ATP2B4, CAMK4, GRIN2D, F2R | More | |
| Levomenthol | hsa04064 | NF-kappa B signaling pathway | 4.92E-02 | 6 | P10415, P51617, Q13546, Q9UDY8, Q13077, P24522 | BCL2, IRAK1, RIPK1, MALT1, TRAF1, GADD45A | More | |
| Levomenthol | hsa04070 | Phosphatidylinositol signaling system | 4.07E-02 | 4 | P0DP23, Q14643, O14732, P17252 | CALM1, ITPR1, IMPA2, PRKCA | More | |
| Levomenthol | hsa04071 | Sphingolipid signaling pathway | 6.38E-04 | 9 | P17252, Q9H228, P01375, Q13362, Q16537, Q9BX95, Q16539, P04637, P10415 | PRKCA, EDG8, TNF, PPP2R5C, PPP2R5E, SGPP1, MAPK14, TP53, BCL2 | More | |
| Levomenthol | hsa04145 | Phagosome | 1.86E-02 | 5 | P63261, Q15080, Q13509, P68371, P27824 | ACTG1, NCF4, TUBB3, TUBB2C, CANX | More | |
| Levomenthol | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | |
| Levomenthol | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.44E-02 | 5 | Q16537, P0DP23, P17252, P10415, P20020 | PPP2R5E, CALM1, PRKCA, BCL2, ATP2B1 | More | |
| Levomenthol | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | |
| Levomenthol | hsa04371 | Apelin signaling pathway | 9.26E-03 | 5 | P62873, Q13485, P84022, Q16566, P0DP23 | GNB1, SMAD4, SMAD3, CAMK4, CALM1 | More | |
| Levomenthol | hsa04390 | Hippo signaling pathway | 1.47E-02 | 5 | P63261, Q13485, Q9UJU2, O43623, Q13489 | ACTG1, SMAD4, LEF1, SNAI2, BIRC3 | More | |
| Levomenthol | hsa04510 | Focal adhesion | 3.21E-02 | 6 | Q15942, P17252, Q13489, P10415, P49767, P63261 | ZYX, PRKCA, BIRC3, BCL2, VEGFC, ACTG1 | More | |
| Levomenthol | hsa04520 | Adherens junction | 3.36E-02 | 4 | Q13485, Q9UJU2, O43623, P63261 | SMAD4, LEF1, SNAI2, ACTG1 | More | |
| Levomenthol | hsa04540 | Gap junction | 4.76E-02 | 3 | P17252, Q13509, P68371 | PRKCA, TUBB3, TUBB2C | More | |
| Levomenthol | hsa04610 | Complement and coagulation cascades | 1.12E-05 | 1 | P0C0L4 | C4A | More | |
| Levomenthol | hsa04613 | Neutrophil extracellular trap formation | 4.32E-04 | 17 | P17252, O60603, P05164, P08246, Q9UM07, Q92769, Q6FI13, P33778, P14598, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, HDAC2, H2AC18; H2AC19, H2BC3, NCF1, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | |
| Levomenthol | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | |
| Levomenthol | hsa04640 | Hematopoietic cell lineage | 1.64E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
| Levomenthol | hsa04657 | IL-17 signaling pathway | 5.61E-03 | 9 | P08238, O00463, Q07955, Q16539, P14780, Q9UJX4, P04141, P80188, P01375 | HSP90AB1, TRAF5, SFRS1, MAPK14, MMP9, ANAPC5, CSF2, LCN2, TNF | More | |
| Levomenthol | hsa04658 | Th1 and Th2 cell differentiation | 1.85E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
| Levomenthol | hsa04659 | Th17 cell differentiation | 1.64E-03 | 2 | P20036, P04234 | HLA-DPA1, CD3D | More | |
| Levomenthol | hsa04666 | Fc gamma R-mediated phagocytosis | 2.22E-02 | 4 | P49006, P06396, P14598, P17252 | MARCKSL1, GSN, NCF1, PRKCA | More | |
| Levomenthol | hsa04672 | Intestinal immune network for IgA production | 3.16E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Levomenthol | hsa04720 | Long-term potentiation | 3.70E-04 | 5 | P17252, Q16566, P0DP23, O15399, Q14643 | PRKCA, CAMK4, CALM1, GRIN2D, ITPR1 | More | |
| Levomenthol | hsa04744 | Phototransduction | 5.92E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | |
| Levomenthol | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.93E-02 | 1 | Q9Y5S1 | TRPV2 | More | |
| Levomenthol | hsa04912 | GnRH signaling pathway | 4.42E-02 | 3 | P17252, Q14643, P0DP23 | PRKCA, ITPR1, CALM1 | More | |
| Levomenthol | hsa04916 | Melanogenesis | 3.55E-02 | 3 | P0DP23, Q9UJU2, P17252 | CALM1, LEF1, PRKCA | More | |
| Levomenthol | hsa04921 | Oxytocin signaling pathway | 4.19E-02 | 4 | P0DP23, P17252, Q16566, P63261 | CALM1, PRKCA, CAMK4, ACTG1 | More | |
| Levomenthol | hsa04925 | Aldosterone synthesis and secretion | 2.90E-04 | 6 | Q14643, P0DP23, P17252, Q16566, P20020, P23634 | ITPR1, CALM1, PRKCA, CAMK4, ATP2B1, ATP2B4 | More | |
| Levomenthol | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.05E-03 | 6 | P84022, Q13485, P10415, Q12778, P49767, P17252 | SMAD3, SMAD4, BCL2, FOXO1, VEGFC, PRKCA | More | |
| Levomenthol | hsa04940 | Type I diabetes mellitus | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Levomenthol | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Levomenthol | hsa04966 | Collecting duct acid secretion | 2.32E-03 | 3 | P02730, P00918, Q9Y666 | SLC4A1, CA2, SLC12A7 | More | |
| Levomenthol | hsa04970 | Salivary secretion | 8.71E-04 | 5 | Q14643, P20020, P23634, P17252, P0DP23 | ITPR1, ATP2B1, ATP2B4, PRKCA, CALM1 | More | |
| Levomenthol | hsa04971 | Gastric acid secretion | 4.76E-02 | 3 | P17252, P63261, P0DP23 | PRKCA, ACTG1, CALM1 | More | |
| Levomenthol | hsa04972 | Pancreatic secretion | 1.00E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | |
| Levomenthol | hsa04978 | Mineral absorption | 3.94E-02 | 2 | P23634, Q9BXS9 | ATP2B4, SLC26A6 | More | |
| Levomenthol | hsa05014 | Amyotrophic lateral sclerosis | 4.31E-02 | 7 | O15399, P10415, Q13509, P68371, Q53GS7, P63261, Q9GZY0 | GRIN2D, BCL2, TUBB3, TUBB2C, GLE1, ACTG1, NXF2; NXF2B | More | |
| Levomenthol | hsa05031 | Amphetamine addiction | 1.49E-02 | 4 | O15399, P0DP23, Q16566, P17252 | GRIN2D, CALM1, CAMK4, PRKCA | More | |
| Levomenthol | hsa05034 | Alcoholism | 4.38E-02 | 5 | Q16566, P0DP23, P62873, O60814, P68431 | CAMK4, CALM1, GNB1, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
| Levomenthol | hsa05132 | Salmonella infection | 2.12E-04 | 13 | P51617, Q9UJU2, P63261, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, P51808, Q13561, Q13509, P68371 | IRAK1, LEF1, ACTG1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DYNLT3, DCTN2, TUBB3, TUBB2C | More | |
| Levomenthol | hsa05133 | Pertussis | 1.51E-04 | 5 | P11215, P0DP23, P23528, P09871, P0C0L4 | ITGAM, CALM1, CFL1, C1S, C4A | More | |
| Levomenthol | hsa05140 | Leishmaniasis | 1.56E-02 | 5 | P14598, O60603, P49006, P51617, Q15080 | NCF1, TLR2, MARCKSL1, IRAK1, NCF4 | More | |
| Levomenthol | hsa05142 | Chagas disease | 4.93E-02 | 1 | P04234 | CD3D | More | |
| Levomenthol | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Levomenthol | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Levomenthol | hsa05150 | Staphylococcus aureus infection | 4.36E-02 | 2 | P0C0L4, P13646 | C4A, KRT13 | More | |
| Levomenthol | hsa05166 | Human T-cell leukemia virus 1 infection | 9.87E-03 | 2 | P04234, P20036 | CD3D, HLA-DPA1 | More | |
| Levomenthol | hsa05168 | Herpes simplex virus 1 infection | 1.94E-02 | 9 | Q9UKJ0, P01568, Q9GZY0, Q01130, Q13489, Q13398, Q03923, Q9UDV6, P10415 | PILRB, IFNA21, NXF2; NXF2B, SFRS2, BIRC3, ZNF211, ZNF85, ZNF212, BCL2 | More | |
| Levomenthol | hsa05169 | Epstein-Barr virus infection | 1.76E-03 | 10 | P20036, Q92769, P04637, Q13546, P10415, P24522, O60603, P51617, P04234, P09693 | HLA-DPA1, HDAC2, TP53, RIPK1, BCL2, GADD45A, TLR2, IRAK1, CD3D, CD3G | More | |
| Levomenthol | hsa05170 | Human immunodeficiency virus 1 infection | 6.54E-03 | 9 | P0DP23, P17252, Q13546, Q14643, P51617, O60603, P09693, P10415, Q9Y6Q5 | CALM1, PRKCA, RIPK1, ITPR1, IRAK1, TLR2, CD3G, BCL2, AP1M2 | More | |
| Levomenthol | hsa05200 | Pathways in cancer | 3.37E-04 | 18 | Q13751, P08238, Q9UJU2, P17252, P43246, P84022, Q13485, P14923, P10415, Q13489, P98170, P49767, Q12778, P25116, P62873, P78417, P0DP23, P01568 | LAMB3, HSP90AB1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, JUP, BCL2, BIRC3, BIRC4, VEGFC, FOXO1, F2R, GNB1, GSTO1, CALM1, IFNA21 | More | |
| Levomenthol | hsa05202 | Transcriptional misregulation in cancer | 1.45E-02 | 12 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P35226, P05164, P08246, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, BMI1, MPO, ELA2, GADD45A | More | |
| Levomenthol | hsa05212 | Pancreatic cancer | 3.40E-02 | 1 | P37173 | TGFBR2 | More | |
| Levomenthol | hsa05214 | Glioma | 9.03E-05 | 7 | P09619, P0DP23, Q16566, P17252, Q02750, P04637, P24522 | PDGFRB, CALM1, CAMK4, PRKCA, MAP2K1, TP53, GADD45A | More | |
| Levomenthol | hsa05216 | Thyroid cancer | 1.85E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | |
| Levomenthol | hsa05217 | Basal cell carcinoma | 4.42E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | |
| Levomenthol | hsa05218 | Melanoma | 1.34E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | |
| Levomenthol | hsa05230 | Central carbon metabolism in cancer | 4.10E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | |
| Levomenthol | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.93E-02 | 1 | P04234 | CD3D | More | |
| Levomenthol | hsa05310 | Asthma | 2.71E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Levomenthol | hsa05320 | Autoimmune thyroid disease | 3.60E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Levomenthol | hsa05321 | Inflammatory bowel disease | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Levomenthol | hsa05330 | Allograft rejection | 3.60E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Levomenthol | hsa05332 | Graft-versus-host disease | 4.05E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Levomenthol | hsa05340 | Primary immunodeficiency | 1.81E-02 | 1 | P04234 | CD3D | More | |
| Levomenthol | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
| Levomenthol | hsa05416 | Viral myocarditis | 4.49E-02 | 1 | P20036 | HLA-DPA1 | More | |
| Levomenthol | hsa05418 | Fluid shear stress and atherosclerosis | 2.31E-02 | 5 | P78417, P63261, P10415, P0DP23, Q92974 | GSTO1, ACTG1, BCL2, CALM1, ARHGEF2 | More | |
